ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 673141 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 673141; 2) Community: the network communities that were significantly associated with the response to NSC 673141; 3) Molecule: the relationships between components within communities and NSC 673141; 4) MDR: the compounds that were significantly associated with the NSC 673141.

NSC Compound Enrichment Correlation
NSC 113943 6-Bromosangivamycin 0.0430505868034761 0.4568394
NSC 121868 Null 0.0430505868034761 0.35709527
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0430505868034761 0.38912214
NSC 134459 Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) 0.0430505868034761 0.36138927
NSC 164970 Propanedinitrile, [(3,5-dibromo-2-ethoxyphenyl)methylene]- 0.0430505868034761 0.39293113
NSC 168516 Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- 0.0430505868034761 0.17349141
NSC 176328 Ellipticine, 6-(3-aminopropyl)-, dihydrochloride 0.0430505868034761 0.20348194
NSC 201873 Null 0.0430505868034761 0.10416793
NSC 208885 Null 0.0430505868034761 0.16437882
NSC 217697 Quinoline, 6,6'-methylenebis[1,2-dihydro-2,2,4-trimethyl]- 0.0430505868034761 0.27882393
Total:147  Current:126    [First] [Prev] [Next] [Last]